Company intelligence
DELPHI
Consulting on the psychedelic frontier with wisdom and integrity.
About DELPHI
DELPHI, under the leadership of Lia Mix, LMFT, CPTR, emerges as a beacon in the psychedelic domain, offering deep insights and expert guidance for healthcare transformation through psychedelics. Specializing in consultancy in organization strategy, fundraising, research & development, and government interfacing, Delphi empowers leaders and organizations within this space. Our work, rooted in integrity, wisdom, and empowerment, drives the advancement of psychedelic-assisted therapy and mental health. Delphi's commitment to ethical practices and evidence-based solutions positions us as a pivotal connector in the psychedelic movement.
Verified activity
Signals from DELPHI
3 published signals
Research & Knowledge
DELPHI added more healthy-volunteer research studies to Blossom's Results explorer, including their own place in the explorer and results staying out of the pooled patient estimates.
Reported by Floris Wolswijk
Research & Knowledge
DELPHI expanded the literature on Blossom, including a broader full catalogue of psychedelic research covering research across psychedelics including MDMA and ketamine.
Reported by Floris Wolswijk
Presence & Recognition
DELPHI announced that Delphi founder Lia Mix, CEO, MFT, will be joined by Ean Seeb, Special Advisor on Cannabis and Natural Medicine to Colorado Governor Jared Polis for a 30-minute discussion on September 2nd.
Reported by DELPHI